Sunday, November 23, 2025 | 06:35 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Everstone's healthcare platform acquires stake in CPC Diagnostics

With the strategic investment, Everlife plans to support CPC's manufacturing and distribution capabilities within India and South-East Asia, to become the leading IVD distributor in India

BPL medical, pharmaceuticals,
premium

In the domestic market, BPL has already established itself as a leader in the ECG segment

T E Narasimhan Chennai
Private equity firm Everstone Group’s healthcare platform Everlife  has made its first investment in India by acquiring a stake in Chennai-based CPC Diagnostics. The acquisition will allow the group to include core in-vitro diagnostics (IVD) segments in its portfolio of medical devices and extend its geographical presence in India.

With the strategic investment, Everlife plans to support CPC’s manufacturing and distribution capabilities within India and South-East Asia, to become the leading IVD distributor in India.

Founded in 1987, CPC Diagnostics (CPC) is a medical devices manufacturer and distributor with a presence across India, Sri Lanka and Bangladesh, and exports to